Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Abstract Text:

Eva ,Marta Crespo,Ana ,Eva Calpe,Maria Joao Baptista,Neus Villamor,Emili Montserrat,Francesc Bosch,

BACKGROUND: The aim of this study was to analyze whether in chronic lymphocytic leukemia the cytosolic release of histone H1.2, a new apoptogenic mechanism induced by DNA damage, was associated with the presence of genetic abnormalities and with the response to treatment. DESIGN AND METHODS: Primary tumoral chronic lymphocytic leukemia cells from 25 patients were investigated for histone H1.2 cytosolic release after treatment with genotoxic (fludarabine, mitoxantrone, etoposide, or X-ray radiation) and non-genotoxic (dexamethasone) agents. Cases were analyzed for the presence of poor-risk genetic alterations, particularly deletions at 17p13 and 11q22. Histone H1.2 release was correlated with the presence of genetic abnormalities and with the best clinical response obtained with standard treatments. RESULTS: DNA-damaging agents induced H1.2 release in a p53-dependent manner which was confirmed by the lack of H1.2 release in p53-deleted cases. Non-DNA-damaging agents induced release of H1.2 in both p53-deleted and non-deleted chronic lymphocytic leukemia cases. Moreover, nuclear H1.2 release was observed after genotoxic and non-genotoxic treatment independently of ATM function. From a clinical standpoint, the lack of histone H1.2 release correlated with resistance to genotoxic treatment. CONCLUSIONS: In chronic lymphocytic leukemia cells, histone H1.2 traffic was dependent on the p53-status after genotoxic treatment, but could also be induced after treatments that acted independently of p53. By contrast, histone H1.2 release did not seem to be dependent on ATM function. Nuclear histone H1.2 release appears to be an important element in apoptosis induction in chronic lymphocytic leukemia, particularly in cases with abnormal p53 function resistant to conventional treatment.

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Publishing Authors By Initials

E ,M Crespo,A ,E Calpe,MJ Baptista,N Villamor,E Montserrat,F Bosch,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Haematologica

VOLUME: 93

Page Numbers: 75-82

Journal Abbreviation: Haematologica

ISSN: 1592-8721

DAY: 1

MONTH: Jan

YEAR: 2008

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 417435

Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.

AFFILIATION: Department of Hematology, Laboratory of Experimental Hematology, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clínic, University of Barcelona, Barcelona, Spain.

Country: Italy

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Haematologica

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Induction of histone H12 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment Related Publications

• Author's Reply.
• Automated tracking of the mitral valve annulus motion in apical echocardiographic images using multidimensional dynamic programming.
• Blood volume studies in postoperative liver death.
• Cell type complexity in the basal metazoan Hydra is maintained by both stem cell based mechanisms and transdifferentiation.
• Discovering innate immunity genes using differential display: a story of RNA helicases.
• Durability, negative impact, and neuropsychological predictors of tic suppression in children with chronic tic disorder.
• Effect of verapamil on tachycardia-induced early cellular electrical remodeling in rabbit atrium.
• Elevated levels of soluble ST2 protein in dengue virus infected patients.
• Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
• Heterozygosity for the classical galactosemia mutation does not affect ovarian reserve and menopausal age.
• High incidence of hypermethioninaemia in a single neonatal intensive care unit detected by a newly introduced neonatal screening programme.
• Independent design and conduct of clinical trials.
• Induction of histone H1.2 cytosolic release in chronic lymphocytic leukemia cells after genotoxic and non-genotoxic treatment.
• Infant mortality among twins and triplets in rural Bangladesh in 1975-2002.
• Localized shape variations for classifying wall motion in echocardiograms.
• Optimized protocol for the large scale production of HIV pseudovirions by transient transfection of HEK293T cells with linear fully deacylated polyethylenimine.
• Portugal's science plots its future.
• Reversal of portal hypertension and hyperdynamic splanchnic circulation by combined vascular endothelial growth factor and platelet-derived growth factor blockade in rats.
• Signatures of Selection in the Human Olfactory Receptor OR5I1 Gene.
• TRAIL is a novel antiviral protein against dengue virus.
• The evolution of immunity: a low-life perspective.
• Transgenic stem cells in Hydra reveal an early evolutionary origin for key elements controlling self-renewal and differentiation.
• Vascular deterioration in cirrhosis: the big picture.
• [Advances in cervical cancer prevention: HPV vaccines]
• [Development of an oxygen-laughing-gas multipurpose apparatus for obstetrical use.]
• [Function of the public health worker in health education.]
• [Is brown adipose tissue a store of long chain polyunsaturated fatty acids during postnatal developing brain?]
• [Not Available.]
• [Notes on the teaching of hygiene to students of medicine.]
• [Training of sanitation personnel in the field of public health education.]